Creating Shared Value Wednesday, October 17, 1.15pm Moderator Dr. Robert S. Kaplan Marvin Bower Professor of Leadership, Emeritus, Harvard Business School Panellists Gustavo Hernandez Executive Vice President, Pemex Exploration & Production John W. Walsh Founder & President, COPD Foundation Michael Kavanaugh Director, Respiratory Boehringer Ingelheim Sikha Singh Director of OSM & HR, Executive Ship Management Creating Shared Value: A Short Overview Bob Kaplan Marvin Bower Professor of Leadership
Words: 1037 - Pages: 5
Pulmonary Problems Chapter 10 Pneumonia is inflammation of the lungs resulting in consolidation Obstruction in gas exchange on the alveolar level Aspiration most common cause 2nd most frequent cause is droplet inhalation Least likely cause is blood borne Protein rich fluid move into the alveoli- complicated by production of the organism- result is decreased alveolar surface area-resulting in elevation of pco2 and a decrease in po2 Inspection-tachypnea and central cyanosis Percussion-dullness
Words: 1122 - Pages: 5
Every individual goes through different experiences while their getting older. When people age they tend to have problems these can be caused by the difference their body goes through, also this tends to happen to people who are more into their fifties. Even people who have passed the stage of 50’s can still have issues caused by the changes, which they still need to get used to because there’s no way it will change. Physical changes- while a person is aging their bodies go through many changes;
Words: 1418 - Pages: 6
Making a difference in the life of a smoker. | Epidemiological Rationale for Topic (statistics related to topic): * Tobacco is the #1 risk factor for preventable death and disease in Canada * 7 Million canadians smoke; 45,000 die every year * economic burden is high * tobacco contributes to chronic diseases & exacerbations (i.e: COPD). Nursing Diagnosis: Readiness for Self Help Management, secondary to decision to quit smoking and reduce COPD exacerbations. Readiness
Words: 1056 - Pages: 5
Importance of Nutritious Diet Name: Karamdeep Kaur Course: Health Safety Date: 01/26/2014 Introduction Chronic obstructive pulmonary disease /COPD (an inflammatory illness) is renowned as a leading cause of death throughout the world. Still, varied curative practices can efficiently regulate COPD. Out of these practices, “Intake of proper nutrition” is an important ingredient of “Pulmonary rehabilitation programs”. This article talks about the importance of nourishing diet for COPD patients, and
Words: 711 - Pages: 3
Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease also referred to as COPD is the name that identifies a group of lung diseases. These diseases consist of bronchiectasis, chronic bronchitis, emphysema, and refractory asthma. An individual can have COPD for years and not know it. When the disease is in the early stages the symptoms are not completely
Words: 2779 - Pages: 12
NUR 159 Class Information and Procedures B-1 NUR 159 Class Information and Procedures NUR159ClassInformation 3/10/2014 NUR 159 Class Information and Procedures B-2 CLASSROOM BEHAVIOR Refer to Classroom Behavior in Student Nurses Handbook TESTING INFORMATION AND PROCEDURES 1. Silent Test Reviews: Silent test reviews will be conducted after each test. Refer to Test Security in Student Nurses Handbook for further information on test reviews. Students may also schedule individual test
Words: 2993 - Pages: 12
Company History * 1935- Cipla was registered as a public limited company in Mumbai. Khwaja Abdul Hamied, the founder of Cipla (Chemical, Industrial & Pharmaceutical Laboratories) was gave the company all his patent and proprietary formulas for several drugs and medicines, without charging any royalty. * 1941–As the Second World War cuts off drug supplies, the company starts producing fine chemicals, dedicating all its facilities for the war effort and helped British with drugs during
Words: 875 - Pages: 4
13: 1455±1476 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 0903-1936 REVIEW Pulmonary surfactant in health and human lung diseases: state of the art M. Griese Pulmonary surfactant in health and human lung diseases: state of the art. M. Griese. #ERS Journals Ltd 1999. ABSTRACT: Pulmonary surfactant is a complex and highly surface active material composed of lipids and proteins which is found in the fluid lining the alveolar surface
Words: 3087 - Pages: 13
Asthma is a lung disease where you're airways contract, bulge and produces excess mucus. This makes breathing challenging and sets off severe coughing. For many other people asthma is just an Irritation and for many others, it’s more serious and prevents them from doing daily tasks and can lead to life-threatening asthma attacks. Asthma can’t be cured, but the symptoms can be contained. The name asthma comes from the Greek word azien, meaning breathing struggles. Asthma was discovered by a Greek
Words: 935 - Pages: 4
